Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 10, 2016 11:26 AM ET

Healthcare Equipment and Supplies

Company Overview of Access Closure, Inc.

Company Overview

AccessClosure, Inc. operates as a medical device company. It manufactures and distributes medical devices for cardiovascular and peripheral vascular markets. The company offers a Mynx Ace Vascular Closure Device, a MynxGrip Vascular Closure Device, and a Flash Ostial System Dual Balloon Angioplasty Catheter. It serves customers through a network of distributors in the United States and internationally. The company was founded in 2002 and is based in Santa Clara, California. As of May 9, 2014, Access Closure, Inc. operates as a subsidiary of Cardinal Health, Inc.

5452 Betsy Ross Drive

Santa Clara, CA 95054

United States

Founded in 2002

Phone:

408-610-6500

Fax:

408-610-6701

Key Executives for Access Closure, Inc.

Co-Founder and Chairman
Chief Financial Officer
Vice President of Operations
Executive Vice President of Regulatory & Quality Affairs
Vice President of Human Resources
Compensation as of Fiscal Year 2015.

Access Closure, Inc. Key Developments

AccessClosure, Inc. Presents at Medical Device Conference 2015, Jun-26-2015 12:10 PM

AccessClosure, Inc. Presents at Medical Device Conference 2015, Jun-26-2015 12:10 PM. Venue: Palace Hotel, 2 New Montgomery Street, San Francisco, California, United States. Speakers: Gregory David Casciaro, Chief Executive Officer, President and Director.

AccessClosure Inc. Launches Mynx Ace Vascular Closure Device

AccessClosure Inc. has commercially launched its Mynx Ace Vascular Closure Device, a safe and secure vascular closure product that provides consistent results with a new, easy-to-use deployment system1 to seal femoral artery access sites. The device joins the pioneering line of Mynx extravascular products that help care teams reduce time to hemostasis and ambulation in patients who have undergone diagnostic or interventional endovascular procedures. Mynx closure devices are designed for patient comfort by providing gentle vascular closure without the use of cinching, sutures, or metal implants to enhance patient satisfaction and keep physicians on patient care.2 With Mynx Ace, physicians can consistently close femoral artery access sites through a simple, three-step deployment system. The Mynx Ace system uses AccessClosure's proprietary Grip Technology, a major advancement in sealant technology. Grip Technology employs an extravascular sealant that actively adheres to the artery for safe and secure mechanical closure and dissolves within 30 days, leaving nothing behind in the healed vessel.

Similar Private Companies By Industry

Company Name Region
Poly-Vac, Inc. United States
Consolidated Technologies, Inc. United States
480 Biomedical, Inc. United States
Surgilight, Inc. United States
Braemar, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Access Closure, Inc., please visit www.accessclosure.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.